立即開始
Elmind

XTLB uptrend to profitability

看多
XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB)  
Elmind  
NASDAQ:XTLB   XTL Biopharmaceuticals Ltd.
Trend Analysis
0
0
trendanalysis
XTLB is going to consolidate a little at the current price before continuing on the up trend. We will buy once price pulls back to $3.02 or lower. Taking profits at various levels.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。